What is a minority growth investment?
An investor buys less than half the company, the owner keeps running it, and the money either goes into the business, into the owner's hands, or both. It is the least discussed of the liquidity routes because it does not fit either of the two stories the market tells: it is not a sale and it is not a financing.
The two flavours matter and they are frequently confused. Primary capital is new money issued by the company, which dilutes existing holders and funds growth. Secondary capital is the investor buying existing shares from the owner, which does not dilute the company and puts cash in the owner's pocket. Most real transactions are a blend, and the blend is a negotiation in itself: an investor underwriting a growth thesis wants the money in the business, and an owner seeking diversification wants it in their account.
The reason it deserves attention now is the state of the alternatives. Total US private equity exit value fell 46.3 percent quarter on quarter in the second quarter of 2026 to 102.6 billion dollars, and sponsor-to-sponsor sales fell 57 percent by value with the count down 38 percent to 94, the lowest quarterly mark in at least a decade (PitchBook, Q2 2026 US PE Breakdown, 6 July 2026). Meanwhile distributions imply a capital cycle of roughly seven years for the buyout industry, well beyond historical norms (Bain, Private Equity Midyear Report 2026, 8 June 2026, on MSCI data). An owner selling control today is selling into that. An owner selling a minority is not.
How is it valued, and what does the owner give up?
On the same enterprise value arithmetic as a control sale, and then adjusted for the fact that the buyer is not buying control. The direction of that adjustment is not in dispute; the size of it is, and it is not published. No regulator, exchange or professional body publishes a measured discount for minority stakes in private middle-market companies, and every range quoted for one originates with a firm that arranges these transactions. We are not going to print one.
What can be said precisely is what actually moves the number, which is the protection package rather than the percentage. An investor with strong consent rights, board representation, information rights and a defined liquidity mechanism is not buying an illiquid minority in the way that phrase implies, and will price accordingly. An investor without those things is, and will price accordingly too. Owners who negotiate hard on governance and then express surprise at the valuation have negotiated the valuation.
What the owner gives up is narrower than a sale and wider than most expect. Not day-to-day control: a growth investor does not run operations and does not want to. What changes is the set of decisions that now require somebody else's agreement, and the fact that those decisions include most of the ones an owner would take if the business were doing badly or doing unexpectedly well.
The other thing the owner gives up is the ability to be the only person with a view on when to sell. That is not a governance point. It is the entire point, and it is covered below.
“The percentage is the least interesting number in a minority deal. Twenty percent with three consent rights and no put is a passive holding. Forty-nine percent with a full consent list, a redemption right at year five and a drag on a defined event is a control deal with a founder still running it, and the owner has usually agreed to the second while believing they negotiated the first.”
Where does minority stop being minority?
At four places in the document, none of which is the share register. The first is the consent list, sometimes called reserved matters or protective provisions. A short list covering issuing new shares, changing the constitutional documents, selling the company and taking on debt above a threshold is normal and reasonable. A long list that reaches the annual budget, capital expenditure above a modest number, hiring and firing senior management, entering new markets and changing the dividend policy is operational control exercised by veto.
The second is board composition. One investor director on a board of five is representation. Two investor directors plus an independent director the investor nominates, on a board of five, is a majority of the votes without a majority of the shares.
The third is the anti-dilution and preference stack. A preferred instrument with a liquidation preference sits ahead of the owner's common equity in every outcome, which means the owner's economic share is not the percentage on the register in any scenario other than a strong one. A participating preference goes further and takes the preference and then shares in what remains.
The fourth is the default and remedy provisions. What happens if a covenant in the shareholders agreement is missed, if the business underperforms an agreed plan, or if a payment is not made. Where the remedy is a board shift, a change to the consent list, or an accelerated liquidity right, the investor has bought a contingent control position that costs them nothing unless the business struggles, which is the moment an owner most needs their own hands free.
| Provision | The reasonable version | The version that is control |
|---|---|---|
| Consent list | New shares, constitutional changes, sale of the company, debt above a stated threshold | Annual budget, capital expenditure above a modest number, senior hiring and firing, new markets, dividend policy |
| Board composition | One investor director on a board where the owner side holds the majority | Two investor directors plus an independent the investor nominates, on a board of five |
| Instrument and preference | Common equity alongside the owner, or a preference with no participation | A participating preference that takes its money back and then shares the rest |
| Remedies on underperformance | Information and consultation rights, and a right to appoint an observer | A board shift, an expanded consent list or an accelerated liquidity right triggered by missing a plan |
What liquidity does the investor require, and when?
A defined route out, and in this market they will insist on one, because their own route out has narrowed. The global private equity exit count fell to 1,315 in the first half of 2026, a pace not seen in over a decade (KPMG, Q2 2026 Pulse of Private Equity, July 2026, on PitchBook data), while distributions to fund investors ran near 10 percent a year against a historical average of 25 percent since 2001 (Jefferies Private Capital Advisory, Global Secondary Market Review, published July 2026, as at 30 June 2026). An investor whose own investors are not being paid does not accept a minority position with no exit mechanism.
The mechanisms come in four forms and they are not equivalent. A drag-along, which lets the investor force a sale of the whole company once a threshold or a date is reached. A put option or redemption right, which lets the investor require the company or the owner to buy them out at a formula price. A tag-along, which is protective rather than initiating. And a registration or listing right, which is rarely relevant at this size.
The two that change the owner's life are the drag and the put. A drag converts the owner from someone who decides when to sell into someone who receives notice. A put converts the investment into a debt-like obligation of the company at a future date, and if the formula price is struck on a multiple of earnings or a minimum return, the obligation grows whether or not the business does.
The single most useful question an owner can ask in the first meeting is therefore not about valuation. It is: what is your fund's remaining life, and when do you need this position to be cash? An investor from a fund raised in 2019 with two years of term left is a different counterparty from an investor deploying a 2025 vintage, and the answer determines how hard the exit mechanism will be. It also explains why 54 percent of fund investors expect the number of funds unable to raise a successor to increase over the next two years (Coller Capital, Global Private Capital Barometer, 44th Edition, published 24 June 2026, surveying 108 investors).
When is it the right route?
In three situations. The first is an owner with most of their net worth in a business they want to keep running for another five to ten years. A minority sale takes a meaningful part of the concentration risk off the table without ending the compounding, and it does so without the leverage a recapitalization would add. That comparison is set out in full in a companion article on this site.
The second is a business with a genuine capital need that debt cannot fund at a sensible cost. Total leverage for a borrower below ten million dollars of EBITDA currently clears at 2.50 to 3.25 times, and unitranche in that band prices at 550 to 750 basis points over the reference rate, an all-in cost of 9.15 to 11.15 percent (SPP Capital Partners, Market At A Glance, July 2026, converted at a one-month term rate of 3.65 percent as at 4 August 2026). A business whose growth plan needs more than three turns of capital is not going to get it from a lender, and equity is the honest answer rather than a failure.
The third is preparation for a control sale two or three years out. A minority investor brings a board, a reporting cadence, an audit, and the discipline of somebody outside the family reading the monthly pack. Those are the same artefacts a control buyer will demand, and building them with a partner already invested is easier than building them under diligence.
The case against is equally short. If the owner intends to sell control within roughly two years, a minority round adds a counterparty with consent rights to a process they will otherwise run alone. If the business cannot support outside governance, adding it does not go well. And if the owner's real objective is to take money off the table with no change to how decisions get made, that objective is not available at any price, and it is better to learn that before the term sheet than after it.
One honest gap. No independent series publishes minority growth investment volume for the lower middle market, or the size of the discount applied to minority positions in private companies. Both are quoted widely and neither is measured by anyone independent, so neither appears here.
As of August 2026
Sources: PitchBook, Q2 2026 US PE Breakdown, published 6 July 2026 as at 30 June 2026, for US private equity exit value of $102.6 billion down 46.3% quarter on quarter and sponsor-to-sponsor sales down 57% by value with the count down 38% to 94, the lowest quarterly mark in at least a decade; KPMG, Q2 2026 Pulse of Private Equity, July 2026, on PitchBook data, for a global private equity exit count of 1,315 in the first half of 2026, described as a pace not seen in over a decade; Jefferies Private Capital Advisory, Global Secondary Market Review, published July 2026 as at 30 June 2026, for annual distribution yield from fund investor portfolios running near 10% against a historical average of 25% since 2001; Bain, Private Equity Midyear Report 2026, published 8 June 2026 on MSCI data, for distributions implying a capital cycle of roughly seven years for the buyout industry, well beyond historical norms; Coller Capital, Global Private Capital Barometer, 44th Edition, published 24 June 2026, surveying 108 fund investors representing more than $2 trillion of assets, for 54% expecting the number of funds unable to raise a successor to increase over the next two years; SPP Capital Partners, Market At A Glance, July 2026, for total leverage of 2.50x to 3.25x and senior non-bank spreads of 550 to 750 basis points below $10 million of EBITDA, converted to an all-in cost at one-month term SOFR of 3.65% as at 4 August 2026. No regulator, exchange or professional body publishes a minority-stake discount for private middle-market companies or a growth equity volume series for the lower middle market; sources offering either are content-marketing pages without stated methodology or trade material predating 2024, and no figure has been substituted for either. The four provisions, the three cases for and the three cases against are drawn from our own mandate and investing practice. Nothing here is legal or tax advice. Companion articles on this site cover choosing between a recapitalization, a refinancing and a full sale, what rolling equity into a buyer's structure is actually worth, and what selling control to a sponsor means for the second bite.

